Human immunodeficiency virus (HIV) is a rare cause of thrombotic microangiopathies (TMA), that can present either with normal ADAMTS13 activity (referred as HIV-related TMA) or suppressed ADAMTS13 activity (referred as HIV-related acquired thrombotic thrombocytopenic purpura, aTTP). The distinct characteristics and management of these two conditions is poorly known, given their rarity and often overlapping features. Here, we report the case of a 46-year-old female patient with TTP who received a diagnosis of HIV infection at her ADAMTS13 relapse and obtained complete remission only with antiretroviral therapy (ART). Moreover, we summarize the existing evidence in the literature about clinical presentation, outcomes and treatment of HIV-related aTTP/TMA.

Acquired thrombotic thrombocytopenic purpura and HIV infection: a case report and review of the literature / S. Rao, A. Liparoti, J.A. Giannotta, A. Artoni, A. Muscatello, A. Bandera, F. Peyvandi. - In: ANNALS OF HEMATOLOGY. - ISSN 1432-0584. - 105:2(2026), pp. 37.1-37.6. [10.1007/s00277-026-06733-7]

Acquired thrombotic thrombocytopenic purpura and HIV infection: a case report and review of the literature

S. Rao
Primo
;
A. Liparoti
Secondo
;
J.A. Giannotta;A. Artoni;A. Bandera
Penultimo
;
F. Peyvandi
Ultimo
2026

Abstract

Human immunodeficiency virus (HIV) is a rare cause of thrombotic microangiopathies (TMA), that can present either with normal ADAMTS13 activity (referred as HIV-related TMA) or suppressed ADAMTS13 activity (referred as HIV-related acquired thrombotic thrombocytopenic purpura, aTTP). The distinct characteristics and management of these two conditions is poorly known, given their rarity and often overlapping features. Here, we report the case of a 46-year-old female patient with TTP who received a diagnosis of HIV infection at her ADAMTS13 relapse and obtained complete remission only with antiretroviral therapy (ART). Moreover, we summarize the existing evidence in the literature about clinical presentation, outcomes and treatment of HIV-related aTTP/TMA.
ADAMTS133; Caplacizumab; HAART; HIV; TTP-like syndrome; Thrombotic thrombocytopenic purpura;
Settore MEDS-05/A - Medicina interna
2026
Article (author)
File in questo prodotto:
File Dimensione Formato  
Rao ANN HEMAT.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Licenza: Creative commons
Dimensione 679.21 kB
Formato Adobe PDF
679.21 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1213336
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
  • OpenAlex 0
social impact